Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-006220

Chief Medical Officer sold 919 shares at $15.00 ($13,785)

  • Chief Medical Officer acquired 919 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DAVIS JOHN C. JR Chief Medical Officer 2019-12-20 Option exercise +114 $9.49 $1,082 8,418 D
DAVIS JOHN C. JR Chief Medical Officer 2019-12-20 Option exercise +805 $9.49 $7,639 9,223 D
DAVIS JOHN C. JR Chief Medical Officer 2019-12-20 Sale −919 $15.00 $13,785 8,304 D
Derivatives
DAVIS JOHN C. JR Chief Medical Officer 2019-12-20 Option exercise · Stock Option (Right to Buy) −805 236,239 D
DAVIS JOHN C. JR Chief Medical Officer 2019-12-20 Option exercise · Stock Option (Right to Buy) −114 236,125 D
Open-market sales · 919 sh · avg $15.00 · $13,785
Loading xslF345X03/primarydocument.xml…